About Avation
Avation is a company based in Columbus (United States) founded in 1999 by Manish Vaishya. It operates as a Direct-to-Consumer (D2C) and HealthTech. Avation has raised $34.92 million across 2 funding rounds from investors including Medtronic, Asahi Kasei and ShangBay Capital. Avation offers products and services including Vivally® System. Avation operates in a competitive market with competitors including Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others.
- Headquarter Columbus, United States
- Founders Manish Vaishya
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Avation Medical
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$34.92 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series C
Feb 01, 2024
-
Investors
Medtronic
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avation
Avation offers a comprehensive portfolio of products and services, including Vivally® System.
Wearable treatment for overactive bladder is provided.
People of Avation
Unlock access to complete
Unlock access to complete
Funding Insights of Avation
Avation has successfully raised a total of $34.92M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $22 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avation
Avation has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Asahi Kasei and ShangBay Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Angelini Ventures is focused on investing in BioTech and Digital Health.
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked |
Investor details for Avation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avation
Investment portfolio details for Avation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avation
Detailed financials for Avation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avation Comparisons
Peer comparison for Avation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avation
Avation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tulavi Nerve Therapeutics, BioCircuit, RxFunction, Epineuron and Monarch Bioimplants, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| Locked | Locked | Locked |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| Locked | Locked | Locked |
Wearable prostheses for sensory peripheral neuropathy patients are developed.
|
|
| Locked | Locked | Locked |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| Locked | Locked | Locked |
Developer of bioimplant for peripheral nerve repair
|
Detailed competitors of Avation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avation
Complete news archive for Avation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avation
Avation was founded in 1999 and raised its 1st funding round 22 years after it was founded.
Avation is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Avation is a funded company, having raised a total of $34.92M across 2 funding rounds to date.
Avation is focused on providing innovative solutions for overactive bladder (OAB) through the Vivally System, a wearable at-home treatment. The system is FDA-cleared and targets symptoms like incontinence and urgency with physiologic closed-loop controlled transcutaneous tibial nerve stimulation. It is supported by a mobile app for tracking progress and customer care for patient assistance. The healthcare sector is primarily served, with solutions designed for both patients and providers to improve quality of life.
Avation's top competitors include Tulavi Nerve Therapeutics, Epineuron and RxFunction.
Avation offers Vivally® System.
Avation has 7 investors. Key investors include Medtronic, Asahi Kasei, ShangBay Capital, Angelini Ventures, and JobsOhio.